Calendar
event
Ex dividend date
30 Jun 2025
calendar_clock
Next Dividend Payment
31 Jul 2025
About Stryker Corporation
Ticker
info
SYK
Trading on
info
NYSE
ISIN
info
US8636671013
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Kevin A. Lobo
Headquarters
info
1941 Stryker Way, Portage, MI, United States, 49002
Employees
info
53,000
Website
info
stryker.com
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Metrics
BasicAdvanced
Market cap
info
$150B
P/E ratio
info
52.86
EPS
info
$7.42
Dividend Yield
info
0.87%
Beta
info
0.94
Forward P/E ratio
info
29.5
EBIDTA
info
$6.18B
Ex dividend date
info
2025-06-30
Price & volume
Market cap
info
$150B
Average daily volume
info
1.5M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$3.28
Dividend yield
info
0.87%
Forward dividend per share
info
$3.36
Forward dividend yield
info
0.87%
Payout ratio
info
26.18%
Valuation
P/E ratio
info
52.86
Forward P/E
info
29.5
PEG ratio
info
0.51
Trailing P/E
info
52.86
Price to sales
info
6.46
Price to book
info
7.16
Earnings
EPS
info
$7.42
EPS estimate (current quarter)
info
$2.73
EPS estimate (next quarter)
info
$3.14
EBITDA
info
$6.18B
Revenues (TTM)
info
$23.2B
Revenues per share (TTM)
info
$60.89
Technicals
Beta
info
0.94
52-week High
info
$405.25
52-week Low
info
$312.78
50-day moving average
info
$367.67
200-day moving average
info
$368.13
Short ratio
info
2.91
Short %
info
1.57%
Management effectiveness
ROE (TTM)
info
14.26%
ROA (TTM)
info
7.49%
Profit margin
info
12.31%
Gross profit margin
info
$15B
Operating margin
info
19.30%
Growth
Quarterly earnings growth (YoY)
info
17.60%
Quarterly revenue growth (YoY)
info
11.90%
Share stats
Outstanding Shares
info
382M
Float
info
344M
Insiders %
info
5.37%
Institutions %
info
80.53%
Analyst Insights & forecasts
info

69% Buy

28% Hold

3% Sell

Based on information from 32 analysts.

Average price target

info
$423.98
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$2.81
$2.79
0.72%
Q2 • 24Beat
$2.87
$2.77
3.61%
Q3 • 24Beat
$4.01
$3.87
3.62%
Q4 • 24Beat
$2.84
$2.73
4.03%
Q1 • 25Beat
-
-
-
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$6.44B
$546M
8.48%
Q4 • 24
$5.87B
$654M
11.15%
Q1 • 25
8.86%
19.78%
31.42%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$43B
$22.3B
51.98%
Q4 • 24
$46B
$25.1B
54.51%
Q1 • 25
7.06%
12.26%
4.86%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$1.93B
$-303M
$-1.79B
$1.67B
Q4 • 24
$250M
$-4.14B
$2.53B
$127M
Q1 • 25
87.05%
1,265.02%
241.25%
92.37%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Stryker Corporation share?
Collapse

Stryker Corporation shares are currently traded for undefined per share.

How many shares does Stryker Corporation have?
Collapse

Stryker Corporation currently has 382M shares.

Does Stryker Corporation pay dividends?
Collapse

Yes, Stryker Corporation does pay dividends.

What is Stryker Corporation 52 week high?
Collapse

Stryker Corporation 52 week high is $405.25.

What is Stryker Corporation 52 week low?
Collapse

Stryker Corporation 52 week low is $312.78.

What is the 200-day moving average of Stryker Corporation?
Collapse

Stryker Corporation 200-day moving average is $368.13.

Who is Stryker Corporation CEO?
Collapse

The CEO of Stryker Corporation is Kevin A. Lobo.

How many employees Stryker Corporation has?
Collapse

Stryker Corporation has 53,000 employees.

What is the market cap of Stryker Corporation?
Collapse

The market cap of Stryker Corporation is $150B.

What is the P/E of Stryker Corporation?
Collapse

The current P/E of Stryker Corporation is 52.86.

What is the EPS of Stryker Corporation?
Collapse

The EPS of Stryker Corporation is $7.42.

What is the PEG Ratio of Stryker Corporation?
Collapse

The PEG Ratio of Stryker Corporation is 0.51.

What do analysts say about Stryker Corporation?
Collapse

According to the analysts Stryker Corporation is considered a buy.